The analysis reported in the previous paragraph and our previous observation of the upregulation of KCTD15 in ALL cell lines and patients [14] prompted us to evaluate the expression levels of the protein in acute myeloid leukemia (AML)-derived cell lines. The gene discussed is KCTD15; the disease is acute lymphoblastic leukemia.